Stock ALKS ALKERMES PLC
Add to a list
To use this feature you must be a member
Log inSign up

News Alkermes plc

Equities

ALKS

IE00B56GVS15

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
24.44 USD -0.85% Intraday chart for Alkermes plc +2.86% -11.90%
Apr. 09 Sector Update: Health Care Stocks Edge Higher Pre-Bell Tuesday MT
Apr. 09 Alkermes Says Potential Narcolepsy Drug Improves Wakefulness in Phase 1b Study MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Alkermes Announces Initiation of Vibrance-1 Phase 2 Study Evaluating ALKS 2680 for the Treatment of Narcolepsy Type 1
PR
Alkermes to Report First Quarter Financial Results on May 1, 2024
PR
Alkermes Announces Positive Topline Results from Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients with Narcolepsy Type 2 and Idiopathic Hypersomnia
AQ
BlackBerry, Alkermes rise; Neogen, Tilray Brands fall, Tuesday, 4/9/2024
AQ
Sector Update: Health Care Stocks Edge Higher Pre-Bell Tuesday
MT
Alkermes Says Potential Narcolepsy Drug Improves Wakefulness in Phase 1b Study
MT
Alkermes plc Announces Positive Topline Results from Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients with Narcolepsy Type 2 and Idiopathic Hypersomnia
CI
Alkermes Insider Sold Shares Worth $292,740, According to a Recent SEC Filing
MT
Baird Initiates Alkermes With Outperform Rating, Price Target is $37
MT
Alkermes Announces Appointment of Nancy S. Lurker to Board of Directors
PR
Alkermes Announces Appointment of Nancy S. Lurker to Board of Directors
CI
European Equities Traded in the US as American Depositary Receipts Advance Wednesday
MT
Alkermes Shares Down After Downgrade From UBS
MT
UBS Downgrades Alkermes to Sell From Neutral, Price Target is $25
MT
Piper Sandler Raises Price Target on Alkermes to $39 From $32.54, Maintains Overweight Rating
MT
Sector Update: Health Care Stocks Higher Late Afternoon
MT
Sector Update: Health Care Stocks Higher Thursday Afternoon
MT
Alkermes Shares Rise After Q4 Results, Guidance
MT
Transcript : Alkermes plc, Q4 2023 Earnings Call, Feb 15, 2024
Alkermes Q4 Non-GAAP Earnings, Revenue Increase; 2024 Outlook Issued -- Shares Gain Pre-Bell
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ALKS Stock
  4. News Alkermes plc